[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 17, 2001

Influenza Vaccine for Healthy Working Adults

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthor

JAMA. 2001;285(3):290-292. doi:10.1001/jama.285.3.290

To the Editor: Dr Bridges and colleagues1 attempted to evaluate the economic costs and benefits of influenza vaccination among healthy workers in the United States using a sample of workers at a Ford Motors plant in Dearborn, Mich. It is not possible to conduct a cost-benefit analysis using the results of their study alone because the results of this study were not generalizable to the US population as a whole and because the sample size was too small to capture all relevant health events, such as hospitalizations or deaths. The authors' failure to include all relevant costs from representative data resulted in an inaccurate and incomplete tabulation of societal costs.

First Page Preview View Large
First page PDF preview
First page PDF preview
×